Search Knowledge Base

41 results for "antipsychotic-agents"

Melatonin and melatonin-agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta-analysis pubmed_article
Evidence Source 2022 PMID: 34687076
Selective 5HT3 antagonists and sensory processing: a systematic review pubmed_article
Evidence Source 2022 PMID: 35017671
Pharmacological interventions for prevention of weight gain in people with schizophrenia pubmed_article
Evidence Source 2022 PMID: 36190739
Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries pubmed_article
Evidence Source 2021 PMID: 33591592
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data pubmed_article
Evidence Source 2021 PMID: 33881460
Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis pubmed_article
Evidence Source 2021 PMID: 34495494
Pharmacotherapy for trichotillomania pubmed_article
Evidence Source 2021 PMID: 34582562
Adjunctive folate for major mental disorders: A systematic review pubmed_article
Evidence Source 2020 PMID: 32063563
[Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 3 : Tardive dyskinesia] pubmed_article
Evidence Source 2019 PMID: 30341543
Interventions for prodromal stage of psychosis pubmed_article
Evidence Source 2019 PMID: 31689359
Vitamin E for antipsychotic-induced tardive dyskinesia pubmed_article
Evidence Source 2018 PMID: 29341067
Natural Medicines for Psychotic Disorders: A Systematic Review pubmed_article
Evidence Source 2018 PMID: 29373456
Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review pubmed_article
Evidence Source 2018 PMID: 29548760
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia pubmed_article
Evidence Source 2018 PMID: 29552749
Calcium channel blockers for antipsychotic-induced tardive dyskinesia pubmed_article
Evidence Source 2018 PMID: 29578611
Melatonin for Atypical Antipsychotic-Induced Metabolic Adverse Effects: A Meta-Analysis of Randomized Controlled Trials pubmed_article
Evidence Source 2018 PMID: 29682546
Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis pubmed_article
Evidence Source 2018 PMID: 29732913
Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis pubmed_article
Evidence Source 2018 PMID: 29785555
Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia pubmed_article
Evidence Source 2017 PMID: 28812541
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial pubmed_article
Evidence Source 2016 PMID: 26687300
Antioxidant treatments for schizophrenia pubmed_article
Evidence Source 2016 PMID: 26848926
Interventions for preventing delirium in hospitalised non-ICU patients pubmed_article
Evidence Source 2016 PMID: 26967259
Dementia praecox redux: a systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia pubmed_article
Evidence Source 2015 PMID: 25567553
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia pubmed_article
Evidence Source 2015 PMID: 25866243
Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis pubmed_article
Evidence Source 2015 PMID: 25980333
Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis pubmed_article
Evidence Source 2014 PMID: 25121994
Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review pubmed_article
Evidence Source 2012 PMID: 22722514
A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia pubmed_article
Evidence Source 2012 PMID: 22981812
Antipsychotic-like activity of noni (Morinda citrifolia Linn.) in mice pubmed_article
Evidence Source 2012 PMID: 23082808
Vitamin E for neuroleptic-induced tardive dyskinesia pubmed_article
Evidence Source 2011 PMID: 21328246

Evidence Search Results semantic · quality-ranked

Pharmacological interventions for prevention of weight gain in people with schizophrenia meta_analysis pubmed_article
Quality: 74 2022 PMID: 36190739 DOI: 10.1002/14651858.CD013337.pub2
Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis meta_analysis pubmed_article
Quality: 74 2024 PMID: 37925074 DOI: 10.1016/j.bpsc.2023.10.008
Melatonin and melatonin-agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 61 2022 PMID: 34687076 DOI: 10.1002/hup.2821
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis meta_analysis pubmed_article
Quality: 65 2019 PMID: 31439071 DOI: 10.1017/S0033291719001995
Calcium channel blockers for antipsychotic-induced tardive dyskinesia meta_analysis pubmed_article
Quality: 67 2018 PMID: 29578611 DOI: 10.1002/14651858.CD000206.pub4
Vitamin E for antipsychotic-induced tardive dyskinesia meta_analysis pubmed_article
Quality: 69 2018 PMID: 29341067 DOI: 10.1002/14651858.CD000209.pub3
Selective 5HT3 antagonists and sensory processing: a systematic review systematic_review pubmed_article
Quality: 53 2022 PMID: 35017671 DOI: 10.1038/s41386-021-01255-4
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia meta_analysis pubmed_article
Quality: 66 2018 PMID: 29552749 DOI: 10.1002/14651858.CD000208.pub2
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series systematic_review pubmed_article
Quality: 56 2024 PMID: 39134879 DOI: 10.1007/s00228-024-03738-x
Antioxidant treatments for schizophrenia meta_analysis pubmed_article
Quality: 70 2016 PMID: 26848926 DOI: 10.1002/14651858.CD008919.pub2

View full evidence search →